Can low molecular weight heparin replace unfractionated heparin during peripheral arterial reconstruction? An open label prospective randomized controlled trial

Journal of Vascular Surgery

Volumn 39, Issue 5, 2004, Pages 977-984

  Norgren, Lars ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE SULFATE;

ADULT; AGED; ARTERY RECONSTRUCTION; ARTICLE; BLEEDING; BLOOD VESSEL OCCLUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REOPERATION; SPINAL CORD HEMORRHAGE; SURGICAL MORTALITY; THROMBOSIS; TREATMENT OUTCOME;

EID: 2342522009     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2004.01.033     Document Type: Article

References (10)

1. Swedenborg J, Nydahl S, Egberg N. Low molecular mass heparin instead of unfractionated heparin during infrainguinal bypass surgery. Eur J Vasc Endovasc Surg 1996;11:59-64.
2. Samama CM, Gigou F, Ill P. Low-molecular-weight heparin vs unfractionated heparin in femorodistal reconstructive surgery: a multicenter open randomized study. Enoxart Study Group. Ann Vasc Surg 1995; 9(suppl):S45-53.
3. Farkas JC, Chapuis C, Combe S, Silsiguen M, Marzelle J, Laurian C, et al. A randomised controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing vascular surgery. Eur J Vasc Surg 1993;7:554-60.
4. Palmer AJ, Schramm W, Kirchhof B, Bergemann R. Low molecular weight heparin and unfractionated heparin for prevention of thromboembolism in general surgery: a meta-analysis of randomized clinical trials. Haemostasis 1997;27:65-74.
5. Samama CM, Combe S, Ill P, Barre E, Dreux S, Viars P. Are low-molecular-weight heparins useful for the prophylaxis and treatment of arterial thrombi? Haemostasis 1996;26(suppl 2):57-64.
6. Malm K, Dahlback B, Amljots B. Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury. Plast Reconstr Surg 2003;111:1659-66.
7. Hingorani A, Gramse C, Ascher E. Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patients. J Vasc Surg 2002;36:341-5.
8. Paramo JC, Sendzischew H, Sivina M. Regarding "Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patients." J Vasc Surg 2003;37:700-1.
9. Kujath P, Eckmann C, Misselwitz F. Low-molecular-weight heparin in arterial reconstructive surgery: a double-blind, randomized dose-finding trial. Clin Appl Thromb Hemost 2002;8:337-45.
10. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.